Rituximab in the Intensive Care Unit: A Review of Indications and Clinical Considerations
Journal of Intensive Care Medicine
Published online on December 26, 2025
Abstract
Journal of Intensive Care Medicine, Ahead of Print.
Rituximab, a chimeric monoclonal antibody targeting CD20 on B cells, has become an important therapeutic agent in the intensive care unit (ICU) for a range of immune-mediated conditions. This review explores the current indications, pharmacological ...
Rituximab, a chimeric monoclonal antibody targeting CD20 on B cells, has become an important therapeutic agent in the intensive care unit (ICU) for a range of immune-mediated conditions. This review explores the current indications, pharmacological ...